A randomized, investigator-masked trial determined the effects of oral recombinant human transforming growth factor-a (TGFa) on jejunal mucosal recovery in 75 piglets with rotavirus diarrhea. Rotavirus inoculation of artificially reared piglets induced subtotal (-50%) villus atrophy and watery diarrhea. Dietary TGFa was associated with significant restoration of villus surface area by 4 d postinoculation (p.i.) and complete restoration by 8 d p.i., whereas saline-treated animals required 12 d for recovery. Jejunal segments from clinically recovered TGFatreated piglets showed an increase in electrical resistance across the epithelial barrier in vitro which was proportional to villus height. TGFa treatment for 12 d also produced a 30-50% increase in jejunal mucosal mass (protein content and wet weight), compared with the corresponding values in salinetreated piglets and in uninfected controls. However, oral TGFa did not hasten the resolution of diarrhea, enhance the specific For treatment of infants with severe acute diarrhea, only fiber-containing formulas, smectite (a mineral clay), and bismuth subsalicylate have been shown to improve stool consistency and reduce the duration of diarrhea (1) (2) (3) (4) . However, no treatment has been demonstrated to facilitate mucosal recovery in infants with acute intestinal damage. Breast-fed infants in developing countries have less severe diarrhea and decreased diarrheal mortality compared with formula-fed infants (5) . EGF, a well characterized peptide, is abundant in human milk, duodenal secretions, and saliva and is known to stimulate proliferation of gastrointestinal epithelial cells (6, 7) . TGFa is 174 RHOADS
METHODS

Animals.
Piglets were obtained from a herd of cross-bred swine maintained by the North Carolina School of Agricultural and Life Sciences. Before farrowing, sows were brought to an intensive care facility and scrubbed daily with povidoneiodine. The piglets were caught on towels, taken to an isolated facility, placed in individual cages, and fed hourly (300 mL/ kg/day) with an automatic feeding machine (12) an artificial formula based on cow's nonfat milk solids. This formula has been shown to have no growth stimulatory effect in vitro (13) . Only healthy animals of normal birth weight were enrolled.
Colostrum-deprived piglets are agammaglobulinemic and are idcal for studies of enteritis because they are uniformly susceptible to infection and are not at risk for acquiring enteric infections from the sow. On d 4-5 of life, which is the optimal time for inducing infection (14) , 75 animals were given in 10 mL of diet approximately lo6 group A porcine rotavirus particles (derived from a frozen stock of fecal supernatant of rotavirus-infected piglets). Previous studies showed that animals inoculated in the first week of life uniformly develop viral enteritis, with some variability in the severity of the mucosal (villous) lesion (12) . Body weight was checked every other day; and stool consistcncy was graded as follows: 1, solid feces; 2, soft, looser than normal stools; 3, liquid diarrheal feces. Stool was assayed for rotavirus antigen by Virogen Rotatest (Wampole Laboratories, Cranbury, NJ).
On the day of inoculation, littermates were randomized to one of four groups receiving human recombinant TGFa at concentrations of 0, 15, 60, or 240 pg/L of formula. Vials of TGFa at different concentration were letter coded by the Mead-Johnson Nutritional Group so that investigators were unaware of treatment group. The code was not broken until all enzyme assays and transport studies were completed. Additionally, studies of intestinal morphology were performed by two examiners who were masked with respect to treatment group. Because artificially fed piglets consumed all of their diet except for a brief period (6-12 h) after rotavirus inoculation, we assumed thc TGFa administered was consumed fully. TGFa was kept frozen in aliquots at -20°C, thawed, and added to diet daily at a dilution of 1:104. The lowest concentration of TGFa (15 pg/L) was similar to that of TGFa in human colostrum (2-7 pg/L) (8) . For comparison, porcine and human milk contain EGF at about 150 pg/L (6).
Animals were fasted for 4-8 h before study, anesthetized with 50-70 mg ketamine i.m., and killed with an injection of 2-3 g of sodium pentobarbital. The entire small bowcl beginning 10 cm distal to the suspensory ligament was removed. The mid-jejunum was studied because previous experiments have shown that this is the most severely affected region in porcine rotavirus enteritis (12) . A 20-cm segment obtained at the mid-point of the small intestine was removed and placed in oxygenated Ringer buffer. A 10-cm portion, measured under uniform tension of a 10-g weight, was scraped and homogenized for enzyme, protein, and DNA assays, as described below. The remaining 10 cm were placed in oxygenated transport buffer for studies of tissue bioelectric properties. Two 0.5-1-cm segments wcre placed in 10% formalin for light microscopic evaluation and in Carnoy's fixative for subsequent crypt cell dissection.
All measurements and assays were made by observers unaware of the coding system. Comparison data were obtained from 82 identically reared, uninfected animals. Infected piglets at 8, 12, and 16 d of age were compared with control animals aged 8-10, 10-13, and 14-19 d. We did not study uninfected and rotavirus-exposed piglets concurrently because rotavirus outbreaks occur despite assiduous disinfection of the facility. Some of the enzyme and morphologic data for uninfected animals were reported in previous studies (12, 15) .
Assays of mucosal enzymes and mass. Mucosa was scraped from the jejunal segments on an iced glass plate, divided in half, and homogenized in two iced buffers. The first sample was homogenized (0.1 g of mucosa/mL of buffer) in 0.2 M Tris-HC1, 0.15 M KCI, 2.5 mM EDTA, pH 7.4, at 4°C; immediately frozen in aliquots at -70°C; and assayed within 2-3 wk for lactase, sucrase, alkaline phosphatase, and total and ouabain-inhibitable ATPase (~a + ,~+ -~T p a s e ) activities, as previously described (12, 16) . The second scraping was homogenized in 20 volumes of iced 10 mM Tris-HC1, pH 7.2, for ornithine decarboxylase determination. Measurement of DNA content was performed using a modified fluorescent dye microassay technique (16) . Protein was measured by the method of Lowry et al. (17) .
Ornithine decarboxylase activity was measured in duplicate by a modification of a standard method (7). The 1:20 (wtlvol) homogenate was sonicated and spun at 15,000 X g for 30 min at 4°C. A 90-pL aliquot of the supernatant was placed in an iced 16 X 100-mm glass tube containing 0.5 pCi of DL-[14c]ornithine in 50 p L of a solution of 12 mM dithiothreitol and 1.72 mM DL-ornithine. A 7.5-pL volume of 1 mM pyridoxal phosphate was then added to this mixture. The tube was sealed immediately with a rubber stopper from which was suspended a plastic center well containing a 13 X 20-mm strip of Whatman No. 1 filter paper soaked in 200 p L of methylbenzethonium hydroxide. Tubes were incubated in a 37°C shaking water bath, and the liberated CO, was trapped on the filter paper. At 60 min of incubation, the reaction was stopped by injecting 30% trichloroacetic acid to a final concentration of 10%. After an additional 60 min, the center well was placed in a scintillation vial with 10 mL of Safety-Solve (Research Products International, Mount Prospect, IL) scintillation cocktail and counted. Nonspecific decarboxylation was evaluated by a simultaneous assay in the presence of 25 mM difluoromethylornithine, a specific inhibitor of ornithine decarboxylase, and subtracted from the total CO, released.
Electrical measurements. Jejunum was drawn over a plastic rod, incised longitudinally, and stripped of muscularis propria. Tissues mounted between lucite half-chambers exposing an area of 1.13 cm2 were bathed at 37OC in 10 mL of oxygenated buffer containing (in mM): Na 140, K 5.2, Ca 1.2, Mg 1.2, C1 119.8, HCO, 25, H,PO, 0.4, and HPO, 2.4, pH 7.4. Indomethacin (1 mM) was present in the Ringer solution during tissue stripping and during the flux experiments to minimize prostaglandin-associated C1-secretion. To sustain tissue metabolism, 10 mM glucose was added to the serosal buffer, with equimolar mannitol added on the mucosal side. The PD across the tissue was measured by calomel electrodes in saturated KC1, attached to agar bridges (4 gllOO mL, made up in Ringer buffer) positioned near the surface of the tissue. Epithelia were continuously short-circuited with automatic voltage clamps (World Precision Instruments, New Haven, CT), which compensated for the fluid resistance. Tissues were continuously short-circuited, except for 5-s intervals, when the open circuit PD was measured. Conductance was calculated from the open circuit PD and I,, using Ohm's law. After a 90-min equilibration period, 30 mM D-glucose was added to the mucosal side, balanced by serosal mannitol, and I,, was measured for a subsequent 20-30 min, until stable. The increment in I,, (AI,,) was defined as the difference between the peak I,, and basal I,,.
Intestinal morphology. From each animal, three to eight properly oriented villi and adjacent crypts were identified by an observer masked to treatment group. Images were captured from a Nikon Microphot-FXA with a television camera, and measurements were made by computer-assisted morphometry (Image-Pro 11, Media Cybernetics, Silver Spring, MD). Villous surface area was calculated from villus length and width, using geometric principles which assume the villus to be a prefect cylinder, as previously described in detail (18) .
Epithelial cell proliferation. Segments of small intestine were fixed in Carnoy's reagent and stored in 70% ethanol. At the time of analysis, the tissue was rehydrated, stained with Schiff reagent, placed in 45% acetic acid under a dissecting microscope, and gently teased apart. A coverslip was placed over the tissue, and individual crypts were separated. The number of mitotic figures per crypt was counted with light microscopy. For each segment analyzed, the mean number of mitoses in 10-13 crypts was determined.
Chemicals. Reagents were purchased from Sigma Chemical Co., St. Louis, MO. Rubber stoppers and plastic center wells were purchased from Kontes (Vineland, NJ). Human recombinant TGFa was purchased form Triton Biosciences (Alameda, CA). -~~-[~~~]~r n i t h i n e was purchased from DuPont NEN (Boston, MA). Difluormethylornithine was a gift from Marion Merrell Dow Research Institute (Cincinnati, OH).
Statistics. With the hypothesis that TGFa treatment would stimulate recovery, the Kruskal-Wallis (multiple comparison) test was used to compare data from uninfected and infected pigs. When a significant difference among the five groups was noted, each infected group was compared with the agematched uninfected group with the Mann Whitney U test. To compare daily fecal scores, rotavirus scores, and number of deaths, 2 statistic was used if frequency in each cell was 2 5 ;
Fisher's exact test was used if n < 5. For comparison of piglet weights, normal distribution was assumed (because the sample size was large), and a two-sided unpaired t test was used. Data are mean t SEM.
These studies were approved by the University of North Carolina and North Carolina State University Animal Care Committees.
RESULTS
Clinical Course
Fecal scores (Table 1) . Eighty percent of the infected piglets (60175) developed severe watery diarrhea, with onset 1.6 t 0.2 d pi.. In most cases, explosive diarrhea lasted 1-2 d, followed by loose stools for several more day:;. One of the infected piglets died with severe diarrhea. By 9 d p.i. only 3/32 piglets had loose stools. There were no significant differences between the four groups of infected piglets (saline or 15, 60, or 240 ~g 1 L TGFa), comparing fecal scores at d 4, 8, or 12.
Weight gain (Table I) . Infected piglets generally grew at a slower rate than uninfected animals. By d 12 pi., three of the four groups of rotavirus-inoculated animals had failed to reach a mean weight of 3 kg, the weight of normal uninfected piglets at this age (p < 0.05). The one exception was the group treated with TGFa at 60 pg/L. These piglets had weights similar to those of the uninfected animals.
Rotavirus excretion. Of the 75 inoculated piglets, 61 excreted rotavirus antigen in the stool. Viral excretion began as early as 1 d p.i. and as late as 7 d p.i. Twelve of the 14 piglets with stools which were repeatedly negative for rotavirus antigen were ill, with watery diarrhea. Aclditionally, two piglets had neither diarrhea nor detectable fecal rotavirus antigen, but both were killed at the earliest time point (4 d pi., saline group). In both of these piglets mucosal enzyme activities (lactase and/or N a + ,~+ -A~p a s e ) were below the 95% confidence interval of the mean compared with those of uninfected animals. Thcrefore, all piglets which were negative for rotavirus excretion had either diarrhea or intestinal injury. We have previously found that some infected piglets begin to excrete rotavirus at a later time point (9-16 d pi.) (12) .
The duration of rotavirus excretion was not significantly affected by TGFa treatment. By the 12th day pi., only 2/27 piglets continued to shed viral antigen.
Small Bowel Mucosal Findings
Jejunal morphology (Fig. I) . Comparing TGFa had normal villous height. There was no reduction in villus hcight, compared with villus hcight of normal uninfected piglets, at any time point in the group that received 240 pgiL TGFa. Crypt depth was similar in all animals, regardless of treatment group.
In the infected saline-treated piglets, mucosal villous surface area (absorptive surface) was reduced by -50% at 4 and 8 d p.i. ( y < 0.01 compared with uninfected) (Fig. 1 B) . Crypt cell production (Fig. 2) . The number of mitoses per microdissected crypt was determined in three groups of piglets: infected animals receiving 60 pg/L TGFa or saline treatment Mucosal mass (Fig. 3) . At d 4 and 8 pi., there were no differences in mucosal wet weight, comparing the five groups of piglets. Mucosae of the TGFa-treated piglets, after 12 d of treatment, weighed -50% more than those of saline-treated infected piglets or normal piglets (Fig. 3A, (Fig. 3) . DNA content of TGFa-treated piglet jejunum was not significantly different from that of uninfected piglet intestine, although values were similar to those of salinetreated infected piglets. There was a trend toward increased DNA content in TGFa-treated pig jejunum at 12 d pi., but the difference was not statistically significant.
The proteinIDNA ratio in TGFa-treated jejunum was similar to that of saline-treated infected jejunum at each time point (for example, at 12 d pi., the ratio was 32.5 ? 4.7 mg of proteinlmg of DNA in saline-treated compared with 37.0 -f 5.0 in pigs consuming TGFa = 60 pg/L diet). Table 2 ). Mucosal lactase activity was reduced in rotavirus-infected tissues (with a nadir of enzyme activity at 8 d p.i.). There was a trend for a decrease in lactase activity with increasing postnatal age, as expected with normal development in early weaned animals. By 12 d p.i., the enzyme activity had was comparable to activity in normal intestine in all groups of infected piglets except for a modest decrease in the group receiving 15 pg/L TGFa. Rotavirus enteritis also caused a reduction of mucosal sucrase-specific activity to -33% of normal in saline-treated infected piglets (p < 0.01).
Mucosal enzymes (
Sucrase-specific activity was also reduced in TGFa-treated piglet jejunum. By 8 d p i , sucrase activity had returned to normal only in the group receiving TGFa at 60 pg/mL. By 12 d p.i., sucrase activity was normal in all groups of infected piglets.
Na+,K+-AT~ase activity in the mucosa was reduced by about 50% in infected piglets at 4 and 8 d p.i. and then returned to normal; and there was no significant effect of TGFa treatment on its activity. Alkaline phosphatase activity in the jejunal mucosa was reduced in rotavirus-infected piglets, but this enzyme remained abnormal at all three time points in all treatment groups ( p < 0.05) (not shown). Specific activity of ornithine decarboxylase, the rate-limiting enzyme in polyamine biosynthesis (19) , in infected animals was elevated at d 4-8 p.i. (1.5-2 times compared with uninfected piglets; p < 0.05), but there was no statistically significant difference between mucosal ornithine decarboxylase activity of piglets treated with TGFa and that of their saline-treated littermates (not shown).
Jejunal bioelectric properties and glucose-stimulated Nu+ transport. Resistance (defined as l/conductance) is a measure of mucosal integrity which is governed by the tight junctions. We noted that at d 12 p.i. most epithelial samples from TGFa-treated animals had a high resistance. Furthermore, many more animals with tall jejunal villi (>600 pm) had received TGFa, rather than saline ( p = 0.0094 by Fisher's exact test). Electrical resistance decreases with increasing villus height, but generally increases after viral damage (20) . The relationship between epithelial resistance and villus height was explored. In saline-treated infected piglet jejunum bathed in Ringer buffer in Ussing chambers (n = 14), no significant relationship between villus height and resistance was found (not shown). However, in the (infected) TGFa-treated jejunum, a positive linear correlation between villus height and resistance was observed (r = 0.4, p < 0.001, Fig. 4) . The Na+-absorptive response (AI,,) to mucosal D-glucose was essentially the same, comparing the four groups of infected piglets ( Table 2) .
DISCUSSION
Previous studies of EGF. EGF and TGFa are trophic peptides in saliva, human milk, and intestinal epithelium (21) . In vivo studies, in which EGF was given to animals orally or systemically, have generally shown stirnulatory effects of exogenous EGF on the intestine (7, (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Parenteral EGF has consistently been shown to enhance intestinal proliferation and in some cases to alter the expression of brush border enzymes. Enteral EGF has been shown to enhance mucosal proliferation and/or intestinal disaccharidase activity in normal intestine. In recent studies of rotavirus-infected piglet intestine and methotrexate-injured rat intestine, enteral ECiF added before injury was associated with no clinical improvement, small changes in villus-to-crypt ratio, and a more rapid recovery of mucosal disaccharidases (30, 32) .
Efect of TGFa on mucosal mass and structure. In the present study, dietary TGFa was given at concentrations similar to but greater than those in human milk (8) . Higher than normal concentrations were chosen because human jejunal juice contains proteolytic activity against EGF and TGFa (33). We found that all doses of TGFa (15-240 pg/L) stimulated mucosal villus recovery from rotaviral damage without evidence of functional recovery. Gradual recovery from the rotavirus-induced villus injury required a period of 1 2 d, but jejunum from TGFa-treated animals returned to normal by 8 d p.i. The villi of the 60 pg/L TGFa-treated jejunum were slightly reduced in height at this time point, but the villous surface area was normal. Because viruses in young hosts can induce a prolonged enteropathy, possibly from repeated cycles of enterocyte infection, we wondered if TGFa treatment might have conferred protection against damage. Such an effect has been reported for EGF in preventing gastric mucosal injury and experimental colitis in rats (22, 34) . However, in our studies the onset, severity, and duration of rotavirus diarrhea were no different in the saline-and TGFa-treated animals. Furthermore, Jejunal specific activities in mucosal homogenates (mean i-SEM). Some of the data from age-matched uninfected piglets were from control litters reported in previous studies (11, 19) . Number of observations is in parentheses. Units for lactase and sucrase are prnol~mg-'~min-' and for thc Na,K-ATPase are nmol.mgl.min-I. Data for glucose-stimulated I,, refer to maximal change in transepithelial I,, occurring 10-15 min after 30 mM D.-glucose is added to mucosal and serosal baths. " p < 0.05, "" p < 0.01 compared with uninfected controls. Despite chronic TGFa exposure, which in theory could down-regulate the physiologic receptor (9) , the villi showed an earlier structural recovery (without functional recovery). We believe the increase in crypt cell proliferation to repopulate the injured villi occurred before the 4-d time point, leading to virtually complete restoration of the mucosal surface. In support of an effect on the crypt, there was a modest increase in crypt cell mitotic rate at d 8 in the TGFa-treated bowel (Fig. 2) . In addition, the mucosa became hypertrophied after 12 d of treatment, with greater wet weight and protein content than expected. Mucosal protein content was significantly increased after TGFa treatment, with a similar trend in DNA content (i.e. unchanged protein/DNA ratio). This finding rules against a nonspecific effect, such as tissue edema or altered cell morphology after TGFa treatment. Could the presence of taller villi (in the face of similar DNA content) in the TGFa-treated groups compared with the saline-treated infected group be explained by a difference in enterocyte diameter? We were unable to demonstrate such a difference using our morphometry system and measuring enterocyte height and width (data not shown). More likely, the TGFa affected the shaping of the villi.
The 8-d TGFa-exposed villi (compared with those of salinetreated animals), were actually narrower (p < 0.05) and taller (p < 0.05), with no significant chan,ge in the number of enterocytes per villus (data not shown). 'This change, at least in part, could result from more rapid resolution of the inflammation in the lamina propria, although no obvious differences were noted among the treatment groups.
The villi of TGFa-treated piglet jejunum, whereas normal in height, were populated by cells bearing low digestive enzyme specific activities, suggesting brush border damage or lack of full enterocyte differentiation. The pattern of enzyme activity,
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when expressed per 10-cm bowel length, paralleled the specific activity (not shown). Previous studies of a similar model of infant viral enteritis, transmissible gastroenteritis of piglets, have also demonstrated that recovery of villous height occurs before intestinal enzyme activities return to normal, resulting in a crypt cell-dominated mucosa with reduced disaccharidasespecific activities (35) . Because the activity of digestive enzymes and Naf ,K+-ATPase in the TGFa-treated piglet intestine were not significantly less than activity in the salinetreated control intestine, we do not believe that chronic TGFa exposure interfered with the differentiation of the enterocytes after repair.
Efect of enteral TGFa on jejunal conductance and NU+ transport in vitro. Based on biophysical considerations (36), epithelia with tall villi were expected to have a greater number of paracellular conductance pathways and therefore a lower resistance. Normal jejunum demonstrated no significant relationship between resistance and villus height (not shown). Inasmuch as a relationship was observed in TGFa-treated bowel (Fig. 4) , we conclude that TGFa may stimulate villus elongation and resistance of the intestinal barrier. Acutely administered EGF also increased transepithelial resistance in the rabbit ileum, in some of the studies of Opleta-Madsen et al. (37) . There is other evidence suggesting that activation of the EGFITGFa receptor could change mucosal barrier function. In burned mice, s.c. recombinant human EGF decreased bacterial translocation into mesenteric lymph nodes and improved mucosal sloughing and villus height in the ileum (38) . Interestingly, the EGF receptor has been shown to colocalize with cytoskeletal actin filaments in cultured cells (39) , although the physiologic relevance of this observation is unclear.
We recently found that exposure of piglet jejunum to the cyclooxygenase inhibitor indomethacin reduces piglet jejunal I,, (a measure of C1-secretion) and that prostaglandin E2 reduces epithelial conductance (40) . We therefore attempted in the present study to minimize any effect of prostaglandins on Is, or tissue resistance by bathing tissues in a physiologic saline solution with indomethacin. Changes in current or resistance were therefore expected to be fully attributable to the tissue response to D-glucose in vitro and differences between groups attributable to the presence or absence of TGFa.
Acute exposure of rabbit ileum in vitro to EGF (60 pg/L) has been shown to cause an increase in microvillous surface area and in glucose-facilitated Naf absorption, but the investigators subsequently showed that in vitro TGFa treatment of rabbit jejunum did not have these stimulatory effects (41) . Chronic exposure of piglet intestine to enteral TGFa, in the present study, similarly did not stimulate glucose-coupled Na+ absorption in vitro. Jejunal glucose-sodium cotransport may have recovered fully by 4 d p.i.
In summary, enteral TGFa at concentrations 2-60 times greater than that found in human colostrum markedly enhanced the rate of regeneration of jejunal villi of piglets with rotavirus enteritis. The epithelium remained undifferentiated, as assessed by enzyme-specific activities and transport function, even after 12 d of treatment. Because the diarrhea scores improved rapidly even in the untreated piglets, the clinical implications of the beneficial effect of TGFa on mucosal structural recovery are uncertain. We believe the restoration of mucosal structure in response to TGFa could facilitate recovery in more severe types of diarrhea, when repair is delayed, such as diarrhea associated with malnutrition. In addition, further work should determine whether TGFa coadministration with a stimulator of epithelial differentiation (such as TGFP), promotes recovery.
